Using US patents to attract investors and partners

For emerging companies, a strong US patent portfolio can be far more than a defensive shield: It can be used for marketing and credibility with investors. Because investors and potential partners increasingly use patents as a way to understand value and risk, a strategically built patent portfolio demonstrates that the company understands its market, protects its innovations, and plans for commercial scale. To potential investors and partners in particular, a patent portfolio can accelerate diligence, streamline negotiations, and open doors to licensing and other collaboration opportunities. EIP’s patent attorneys are well-versed in operating at the intersection of law and strategy and therefore excel in advising clients with respect to patents that move intellectual property from technical assets to strategic currency.

What different investors look for
‍Patent value is not perceived in the same way by every potential investor. Venture capital firms, for example, tend to focus on how clearly claims align with the company’s monetization path. They look for evidence that the business can generate protectable assets quickly, meaning that programs like the USPTO’s Track One accelerated examination can be key. A continuation strategy of keeping a pending application alive in patent families related to core technologies matters, too, as it provides for market and product pivots, portfolio expansion, and flexibility in claim strategy. Regardless of the type of patent application, clear ownership (including taking care with respect to properly naming inventors and establishing clean chains of title with proper assignments) is also important.

Corporate venture groups and OEM partners may view patent portfolios through a different lens, prioritizing freedom to operate in large markets and risk clarity. They care about how the portfolio interacts with competitors, relevant standards, and with a coordinated territorial plan: often US first, followed by a Patent Cooperation Treaty (PCT) filing and eventually regional or national filings in key markets like Europe, the UK, and China. For companies operating transatlantically in both US and European/UK markets, integrated IP teams and cross jurisdictional capabilities become powerful differentiators.

Strategic acquirors and licensors, meanwhile, want to see how a patent portfolio maps to a more specific product or legal landscape. They evaluate whether claims can be asserted cleanly, defended credibly, and monetized efficiently. They expect a narrative showing how specific patents support licensing models or expand market reach. This is where prosecution choices made early on can dramatically influence exit pathways later.

Building an investor grade portfolio
‍To maximize both investment potential and partnership opportunities, companies need to file with deliberate commercial intent. Claims should tie directly to revenue drivers and real world use cases. Disclosures and prosecution strategy should leave room for future continuations, giving investors the comfort that the company can adapt as markets evolve.

Acceleration, when used selectively, can be transformative. A rapid US Track One allowance at the right moment—before a term sheet, pilot agreement, or regulatory milestone—can significantly boost confidence of all involved parties. But acceleration should be balanced against cost and longterm claim strength. The goal is not merely speed but strategic timing and use of available capital.

Portfolio hygiene is equally critical. Companies should put in place procedures to capture and document new innovations, carefully review inventorship for accuracy, and establish clear assignment chains.

A strong US patent portfolio can be far more than a defensive shield: It can be used for marketing and credibility with investors

In due diligence, virtual data rooms should be ready early with organized file histories. The smoother the diligence process, the faster investors can make decisions with less opportunity for doubt to creep in.

International strategy also deserves attention. A US allowance paired with an aligned European or Unitary Patent filing increases options (and leverage) in global negotiations. For technologies tied to formal standards, early attention to standards setting trends and potential SEP positioning creates options for future licensing.

Turning patents into partnering assets
‍Patents are not only technical records; they are also marketing documents. Disclosures that are framed in ways that investors and partners can immediately understand (even if they are highly technical legal documents) can provide many advantages. This can include explaining possible technical and market advantages in easy to digest language, while also laying out how innovative product features are strategically claimed. This simple mapping can help non patent specialists grasp value quickly.

Key indicators like portfolio size, allowance rate, continuation filings, and coverage across various products help quantify portfolio strength. These metrics translate complex prosecution work into quantifiable results that resonate with decision makers.

Introductory and supporting materials matter as well. A concise one page summary for each flagship patent or application can make the difference between confusion and clarity during an initial discussion. Visual heatmaps showing portfolio breadth, continuation families, and global filings are increasingly expected in pitch decks. These materials help tell a coherent story: not just that patents exist, but that they are strategically aligned with how the company plans to grow.

From IP to EBITDA
‍Ultimately, a patent portfolio built from the foundation with investor and partnership opportunities considered alongside technical accuracy and legal strategy has high value. This type of portfolio not only protects key innovations but also can attract interest, streamline diligence, and shorten time to deal, thereby increasing value, strengthening defensibility, and leading to positive cash flow. Companies that understand this from the first patent filing are already ahead of the curve in realizing the full potential of the value of their IP.